Additional Information

Notes to editors

• Aviva is the leading provider of life and pension products in Europe (including the UK) with substantial positions in other markets around the world, making it the world’s fifth largest insurance group based on gross worldwide premiums at 31 December 2008.
• Aviva’s principal business activities are long-term savings, fund management and general insurance, with worldwide total sales* of £51.4 billion and funds under management of £381 billion at 31 December 2008.
  
  * Based on 2008 published life and pensions PVNBP on an MCEV basis, total investment sales and general insurance and health net written premiums, including share of associates’ premiums.
  
  The Aviva media centre at www.aviva.com/media includes images, company and product information and a news release archive.
• All figures have been translated at average exchange rates applying for the period. The average rates employed in this announcement are 1 euro = £0. 88 (12 months to 31 December 2008: 1 euro = £0.80) and £1 = US$1.57 (12 months to 31 December 2008: £1 = US$1.85).
• Growth rates in the press release have been provided in sterling terms unless stated otherwise. The supplements following present this information on both a sterling and local currency basis.
• Definition: Present value of new business premiums (PVNBP)
  
  PVNBP is derived from the single and regular premiums of the products sold during the financial period and are expressed at the point of sale. The PVNBP calculation is equal to total single premium sales received in the period plus the discounted value of regular premiums expected to be received over the term of the new contracts. The discount rate used reflects the appropriate risk-free rate for the country and duration of business. The projection assumptions used to calculate PVNBP for each product are the same as those used to calculate new business contribution. The discounted value of regular premiums is also expressed as annualised regular premiums multiplied by a Weighted Average Capitalisation Factor (WACF). The WACF will vary over time depending on the mix of new products sold, the average outstanding term of the new contracts and the projection assumptions.
• Cautionary statements:
  
  This should be read in conjunction with the documents filed by Aviva plc (the “Company” or “Aviva”) with the United States Securities and Exchange Commission (“SEC”).
  
  This announcement contains, and we may make verbal statements containing, “forward-looking statements” with respect to certain of Aviva’s plans and current goals and expectations relating to future financial condition, performance, results, strategic initiatives and objectives. Statements containing the words “believes”, “intends”, “expects”, “plans”, “seeks”, “aims”, “may”, “could”, “outlook”, “estimates” and “anticipates”, and words of similar meaning, are forward-looking. By their nature, all forward-looking statements involve risk and uncertainty. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in these statements. Aviva believes these factors include, but are not limited to: the impact of difficult conditions in the global capital markets and the economy generally the impact of new government initiatives related to the financial crisis defaults in our bond, mortgage and structured credit portfolios the impact of volatility in the equity, capital and credit markets on our profitability and ability to access capital and credit changes in general economic conditions, including foreign currency exchange rates, interest rates and other factors that could affect our profitability risks associated with arrangements with third parties, including joint ventures inability of re insurers to meet obligations or unavailability of reinsurance coverage a decline in our ratings with Standard &Poor’s, Moody’s, Fitch and A.M. Best increased competition in the U.K. and in other countries where we have significant operations changes in assumptions in pricing and reserving for insurance business (particularly with regard to mortality and morbidity trends, lapse rates and policy renewal rates), longevity and endowments a cyclical downturn of the insurance industry changes in local political, regulatory and economic conditions, business risks and challenges which may impact demand for our products, our investment portfolio and credit quality of counterparties the impact of actual experience differing from estimates on amortisation of deferred acquisition costs and acquired value of in-force business the impact of recognising an impairment of our goodwill or intangibles with indefinite lives changes in valuation methodologies, estimates and assumptions used in the valuation of investment securities the effect of various legal proceedings and regulatory investigations the impact of operational risks the loss of key personnel the impact of catastrophic events on our results changes in government regulations or tax laws in jurisdictions where we conduct business funding risks associated with our pension schemes the effect of undisclosed liabilities, integration issues and other risks associated with our acquisitions and the timing impact and other uncertainties relating to acquisitions and disposals and relating to other future acquisitions, combinations or disposals within relevant industries.

For a more detailed description of these risks, uncertainties and other factors, please see Item 3, “Risk Factors”, and Item 5, “Operating and Financial Review and Prospects” in Aviva’s registration statement on Form 20-F as filed with the SEC on 7 October 2009. Aviva undertakes no obligation to update the forward-looking statements in this announcement or any other forward-looking statements we may make. Forward-looking statements in this announcement are current only as of the date on which such statements are made.

Aviva plc is a company registered in England No. 2468686.
Registered office
St Helen's
1 Undershaft
London
EC3P 3DQ